XML 56 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Award Plans and Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2021
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s consolidated statements of operations:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2021

 

 

 

2020

 

 

 

2019

 

 

 

(in $000's)

 

Cost of revenue

 

$

3,760

 

 

$

2,641

 

 

$

2,643

 

Research and development

 

 

6,941

 

 

 

5,534

 

 

 

9,312

 

Selling, general and administrative

 

 

36,305

 

 

 

31,606

 

 

 

42,539

 

 

 

$

47,006

 

 

$

39,781

 

 

$

54,494

 

Components of Stock-Based Compensation

The components of stock-based compensation were as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2021

 

 

 

2020

 

 

 

2019

 

 

 

(in $000's)

 

Restricted stock units

 

$

36,347

 

 

$

28,895

 

 

$

45,998

 

Stock options

 

 

8,982

 

 

 

9,006

 

 

 

7,445

 

Employee stock purchase plan

 

 

1,677

 

 

 

1,880

 

 

 

1,051

 

 

 

$

47,006

 

 

$

39,781

 

 

$

54,494

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the fiscal year ended March 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

869

 

 

$

112.03

 

 

 

5.30

 

 

 

 

 

Granted

 

 

70

 

 

 

225.60

 

 

 

 

 

 

 

 

 

Exercised

 

 

(215

)

 

 

42.16

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(13

)

 

 

248.42

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

711

 

 

$

141.87

 

 

 

5.46

 

 

$

129,912

 

Exercisable at end of period

 

 

537

 

 

$

104.55

 

 

 

4.51

 

 

$

117,880

 

Options vested and expected to vest at end of period

 

 

711

 

 

$

141.87

 

 

 

5.46

 

 

$

129,912

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted were as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2021

 

 

 

2020

 

 

 

2019

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant-date fair value

 

$

77.82

 

 

$

93.05

 

 

$

141.47

 

Risk-free interest rate

 

 

0.32

%

 

 

1.97

%

 

 

2.91

%

Expected option life (years)

 

 

4.22

 

 

 

4.14

 

 

 

4.04

 

Expected volatility

 

 

42.9

%

 

 

42.3

%

 

 

42.8

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

The following table summarizes restricted stock unit activity for the fiscal year ended March 31, 2021:

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

320

 

 

$

263.92

 

Granted

 

 

230

 

 

 

254.78

 

Vested

 

 

(139

)

 

 

227.32

 

Forfeited

 

 

(109

)

 

 

266.57

 

Restricted stock units at end of period

 

 

301

 

 

$

273.57

 

Summary of Assumptions Used To Value Awards And Estimated Grant-Date Fair Value

The table below sets forth the assumptions used to value the awards and the estimated grant-date fair value:

 

Risk-free interest rate

 

 

0.2

%

Expected volatility

 

 

35.5

%

Dividend yield

 

 

 

Remaining performance period (years)

 

1.9 - 2.9

 

Estimated grant date fair value per share

 

$347.05 - $349.28

 

Target performance (number of shares)

 

 

30,881